Vivos Therapeutics, Inc. Increase Decrease In Operating Lease Liability
Vivos Therapeutics, Inc. (VVOS) reported Increase Decrease In Operating Lease Liability of $67.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-14
- Vivos Therapeutics, Inc. increase decrease in operating lease liability for the quarter ending 2026-06-30 was $49.00K.
- Vivos Therapeutics, Inc. increase decrease in operating lease liability for the quarter ending 2026-03-31 was $18.00K.
- Vivos Therapeutics, Inc. increase decrease in operating lease liability for the quarter ending 2025-12-31 was $129.00K.
- Vivos Therapeutics, Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$7.00K.
- Vivos Therapeutics, Inc. increase decrease in operating lease liability for fiscal 2025 was $55.00K.
- Vivos Therapeutics, Inc. increase decrease in operating lease liability for fiscal 2024 was -$129.00K.
- Vivos Therapeutics, Inc. increase decrease in operating lease liability for fiscal 2023 was -$109.00K, a 1657.14% decline from fiscal 2022.
- Vivos Therapeutics, Inc. increase decrease in operating lease liability for fiscal 2022 was $7.00K, a 98.72% decline from fiscal 2021.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 6 month as first filed | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 9 month as first filed | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $49.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $67.00K 10-Q · filed 2026-08-14 | $196.00K derived: sum of 3 quarters · filed 2026-08-14 | $189.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | $18.00K 10-Q · filed 2026-05-20 | $147.00K derived: sum of 2 quarters · filed 2026-05-20 | $140.00K derived: sum of 3 quarters · filed 2026-05-20 | $106.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | $129.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $122.00K derived: sum of 2 quarters · filed 2026-04-15 | $88.00K derived: sum of 3 quarters · filed 2026-08-14 | $55.00K 10-K · filed 2026-04-15 | ||
| 2025-09-30 | -$7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | -$41.00K derived: sum of 2 quarters · filed 2026-08-14 | -$74.00K 10-Q · filed 2025-11-19 | -$108.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | -$34.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$67.00K 10-Q · filed 2026-08-14 | -$101.00K derived: sum of 3 quarters · filed 2026-08-14 | -$134.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-03-31 | -$33.00K 10-Q · filed 2026-05-20 | -$67.00K derived: sum of 2 quarters · filed 2026-05-20 | -$100.00K derived: sum of 3 quarters · filed 2026-05-20 | -$132.00K derived: sum of 4 quarters · filed 2026-05-20 | ||
| 2024-12-31 | -$34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$67.00K derived: sum of 2 quarters · filed 2026-04-15 | -$99.00K derived: sum of 3 quarters · filed 2026-04-15 | -$129.00K 10-K · filed 2026-04-15 | ||
| 2024-09-30 | -$33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | -$65.00K derived: sum of 2 quarters · filed 2025-11-19 | -$95.00K 10-Q · filed 2025-11-19 | -$123.00K derived: sum of 4 quarters · filed 2025-11-19 | ||
| 2024-06-30 | -$32.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19 | -$62.00K 10-Q · filed 2025-08-19 | -$90.00K derived: sum of 3 quarters · filed 2025-08-19 | -$119.00K derived: sum of 4 quarters · filed 2025-08-19 | ||
| 2024-03-31 | -$30.00K 10-Q · filed 2025-05-15 | -$58.00K derived: sum of 2 quarters · filed 2025-05-15 | -$87.00K derived: sum of 3 quarters · filed 2025-05-15 | -$114.00K derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | -$28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$57.00K derived: sum of 2 quarters · filed 2025-03-31 | -$84.00K derived: sum of 3 quarters · filed 2025-03-31 | -$109.00K 10-K · filed 2025-03-31 | ||
| 2023-09-30 | -$29.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$56.00K derived: sum of 2 quarters · filed 2024-11-14 | -$81.00K 10-Q · filed 2024-11-14 | -$81.00K derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | -$27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$52.00K 10-Q · filed 2024-08-14 | -$52.00K derived: sum of 3 quarters · filed 2024-08-14 | -$26.00K derived: sum of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | -$25.00K 10-Q · filed 2024-05-14 | -$25.00K derived: sum of 2 quarters · filed 2024-07-30 | $1.00K derived: sum of 3 quarters · filed 2024-07-30 | $1.00K derived: sum of 4 quarters · filed 2024-07-30 | ||
| 2022-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-07-30 | $26.00K derived: sum of 2 quarters · filed 2024-07-30 | $26.00K derived: sum of 3 quarters · filed 2024-07-30 | $7.00K 10-K/A · filed 2024-07-30 | ||
| 2022-09-30 | $26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $26.00K derived: sum of 2 quarters · filed 2023-11-14 | $7.00K 10-Q · filed 2023-11-14 | -$376.00K 10-Q · filed 2022-12-20 | $359.00K derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-16 | -$19.00K 10-Q · filed 2023-08-16 | -$258.00K 10-Q · filed 2022-12-20 | $333.00K derived: sum of 3 quarters · filed 2023-08-16 | $335.00K derived: sum of 4 quarters · filed 2023-08-16 | |
| 2022-03-31 | -$19.00K 10-Q · filed 2023-06-08 | $333.00K derived: sum of 2 quarters · filed 2023-06-08 | $335.00K derived: sum of 3 quarters · filed 2023-06-08 | |||
| 2021-12-31 | $352.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $354.00K derived: sum of 2 quarters · filed 2023-03-30 | $548.00K 10-K · filed 2023-03-30 | |||
| 2021-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-12-20 | $196.00K 10-Q · filed 2022-12-20 | ||||
| 2021-06-30 | $194.00K 10-Q · filed 2022-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |